Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
Title of document
Medical Devices; Exemption From Premarket Notification: Class II Devices; Flow Cytometer Instruments; Request for Comments (4 page(s), in English)
Description
The Food and Drug Administration (FDA or Agency) is announcing its intention to exempt certain flow cytometer instruments from premarket notification requirements, subject to conditions and limitations. The Agency has determined based on established factors that these devices, which are currently regulated by FDA under product code OYE, no longer require premarket notification to provide reasonable assurance of safety and effectiveness. All other class II devices classified under FDA's automated differential cell counter regulation would continue to be subject to premarket notification requirements. FDA is publishing this proposed order to obtain comments regarding this proposed exemption, in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Notifying member: United States of America
Notification: G/TBT/N/USA/1463
Objective tag
Cost saving and productivity enhancement
Documents
Agency responsible
Food and Drug Administration (FDA), Health and Human Services (HHS) [1491]
Timing:
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions